Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01327404 · ClinicalTrials.gov registry record

Myelin, Glia and Depression in Type 2 Diabetes

A clinical trial, sponsored by University of Illinois at Chicago.

Completed
Registry status
400
Enrollment target

NCT01327404 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01327404 has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

The purpose of the study is to examine the relationship between brain structure and depression in adults aged 30 or older with Diabetes. This relationship is determined using magnetic resonance imaging technology (MRI), a scanner with a magnet that is used to create images of the brain.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2009-10-19
Est. Completion 2014-11

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT01327404

The ClinicalTrials.gov registry entry for NCT01327404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01327404 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01327404 about?

NCT01327404 is a clinical study titled "Myelin, Glia and Depression in Type 2 Diabetes". The purpose of the study is to examine the relationship between brain structure and depression in adults aged 30 or older with Diabetes. This relationship is determined using magnetic resonance imaging technology (MRI), a scanner with a magnet that is used to create images of the brain.

What is the current status of trial NCT01327404?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2009-10-19. Estimated completion is 2014-11.

Who is sponsoring clinical trial NCT01327404?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.